Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Public ClinicalTrials.gov record NCT02968368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Placebo Controlled, Prospective, Multicenter Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
Study identification
- NCT ID
- NCT02968368
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Shield Therapeutics
- Industry
- Enrollment
- 167 participants
Conditions and interventions
Interventions
- Ferric maltol Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- Jan 17, 2018
- Completion
- Oct 9, 2018
- Last update posted
- Nov 1, 2020
2016 – 2018
United States locations
- U.S. sites
- 27
- U.S. states
- 13
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Peoria | Arizona | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Prescott | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | La Mesa | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Coral Springs | Florida | — | — |
| Not listed | Edgewater | Florida | — | — |
| Not listed | Lauderdale Lakes | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Macon | Georgia | — | — |
| Not listed | Shreveport | Louisiana | — | — |
| Not listed | Pontiac | Michigan | — | — |
| Not listed | Roseville | Michigan | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Asheville | North Carolina | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Bethlehem | Pennsylvania | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Nashville | Tennessee | — | — |
| Not listed | El Paso | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Hampton | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02968368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02968368 live on ClinicalTrials.gov.